André Lieber
Impact in
Papers in
- Genetics 149
- Virus-based gene therapy research 145
-
- Viral Infectious Diseases and Gene Expression in Insects 57
- RNA Interference and Gene Delivery 38
- CRISPR and Genetic Engineering 38
- Co-authors
- Dmitry M. Shayakhmetov (33 shared papers)Anuj Gaggar (12 shared papers)Shaoheng Ni (27 shared papers)Mark A. Kay (21 shared papers)Zong-Yi Li (23 shared papers)Robert Strauss (19 shared papers)Dirk S. Steinwaerder (9 shared papers)Thalia Papayannopoulou (17 shared papers)
- Journals
- Journal of Virology (32 papers)Molecular Therapy (24 papers)Blood (13 papers)Human Gene Therapy (13 papers)Molecular Therapy — Methods & Clinical Development (12 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
André Lieber
205 papers receiving 10.3k citations
André Lieber's Hit Papers
Peers
Comparison fields: 5 of 132
- Genetics 6.8k
- Oncology 3.3k
- Infectious Diseases 1.7k
- Molecular Biology 6.2k
- Biotechnology 712
Countries citing papers authored by André Lieber
This map shows the geographic impact of André Lieber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Lieber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Lieber more than expected).
Fields of papers citing papers by André Lieber
This network shows the impact of papers produced by André Lieber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Lieber. The network helps show where André Lieber may publish in the future.
Co-authors
The 25 scholars most cited alongside André Lieber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 210 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CD46 is a cellular receptor for group B adenoviruses Hit paper breakdown → | 2003 | 653 |
| 2 | 1997 | 354 | |
| 3 | 2005 | 335 | |
| 4 | 2010 | 335 | |
| 5 | 2000 | 320 | |
| 6 | 2013 | 277 | |
| 7 | 2006 | 233 | |
| 8 | Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. | 1995 | 219 |
| 9 | 1996 | 188 | |
| 10 | 2004 | 174 | |
| 11 | 2010 | 170 | |
| 12 | 2000 | 167 | |
| 13 | 2011 | 162 | |
| 14 | 2008 | 155 | |
| 15 | 2013 | 146 | |
| 16 | 1995 | 126 | |
| 17 | 2007 | 124 | |
| 18 | 2006 | 122 | |
| 19 | 2009 | 119 | |
| 20 | 2006 | 116 |
About André Lieber
André Lieber is a scholar working on Genetics, Molecular Biology, Oncology, Immunology and Infectious Diseases, having authored 210 papers that have together received 10.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (145 papers), Viral Infectious Diseases and Gene Expression in Insects (57 papers), CAR-T cell therapy research (55 papers), RNA Interference and Gene Delivery (38 papers), CRISPR and Genetic Engineering (38 papers), Viral gastroenteritis research and epidemiology (19 papers), Immunotherapy and Immune Responses (17 papers) and Cancer Research and Treatments (16 papers). The work is most often cited by research in Genetics (6.8k citations), Oncology (3.3k citations), Infectious Diseases (1.7k citations), Molecular Biology (6.2k citations) and Biotechnology (712 citations). André Lieber has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Dmitry M. Shayakhmetov, Anuj Gaggar, Shaoheng Ni, Mark A. Kay, Zong-Yi Li, Robert Strauss, Dirk S. Steinwaerder, Thalia Papayannopoulou, Hongjie Wang and Mike Strauss. Their work appears in journals such as Journal of Virology, Molecular Therapy, Blood, Human Gene Therapy and Molecular Therapy — Methods & Clinical Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.